DK312989A - 1,4-dihydropyridin-threonin-derivater og fysiologisk uskadelige salte deraf, deres fremstilling og anvendelse samt mellemprodukter til fremstillingen - Google Patents

1,4-dihydropyridin-threonin-derivater og fysiologisk uskadelige salte deraf, deres fremstilling og anvendelse samt mellemprodukter til fremstillingen Download PDF

Info

Publication number
DK312989A
DK312989A DK312989A DK312989A DK312989A DK 312989 A DK312989 A DK 312989A DK 312989 A DK312989 A DK 312989A DK 312989 A DK312989 A DK 312989A DK 312989 A DK312989 A DK 312989A
Authority
DK
Denmark
Prior art keywords
preparation
dihydropyridine
intermediates
group
threonine derivatives
Prior art date
Application number
DK312989A
Other languages
English (en)
Other versions
DK312989D0 (da
Inventor
Juergen Stoltefuss
Martin Bechem
Rainer Gross
Siegbert Hebisch
Matthias Schramm
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK312989D0 publication Critical patent/DK312989D0/da
Publication of DK312989A publication Critical patent/DK312989A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/83—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/04—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/06—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • C07C251/08—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton being acyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
DK312989A 1988-06-24 1989-06-23 1,4-dihydropyridin-threonin-derivater og fysiologisk uskadelige salte deraf, deres fremstilling og anvendelse samt mellemprodukter til fremstillingen DK312989A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3821334A DE3821334A1 (de) 1988-06-24 1988-06-24 1,4-dihydropyridin-threonin-derivate, verfahren zu ihrer herstellung, zwischenprodukte und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
DK312989D0 DK312989D0 (da) 1989-06-23
DK312989A true DK312989A (da) 1989-12-25

Family

ID=6357161

Family Applications (1)

Application Number Title Priority Date Filing Date
DK312989A DK312989A (da) 1988-06-24 1989-06-23 1,4-dihydropyridin-threonin-derivater og fysiologisk uskadelige salte deraf, deres fremstilling og anvendelse samt mellemprodukter til fremstillingen

Country Status (18)

Country Link
US (2) US5017590A (da)
EP (2) EP0347678B1 (da)
JP (2) JPH0253774A (da)
KR (1) KR910000643A (da)
CN (1) CN1039583A (da)
AT (2) ATE149154T1 (da)
AU (1) AU3644289A (da)
CA (1) CA1337074C (da)
DD (1) DD284001A5 (da)
DE (3) DE3821334A1 (da)
DK (1) DK312989A (da)
ES (1) ES2098084T3 (da)
FI (1) FI893066A7 (da)
GR (1) GR3022713T3 (da)
HU (1) HUT50772A (da)
IL (1) IL90696A0 (da)
PT (1) PT90943B (da)
ZA (1) ZA894778B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3737340A1 (de) * 1987-11-04 1989-05-24 Bayer Ag Neue fluormethoxyphenyl-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
DE4003541C1 (da) * 1990-02-06 1991-08-08 Alter S.A., Madrid, Es

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1813436C3 (de) * 1968-12-07 1979-01-11 Bayer Ag, 5090 Leverkusen N-Substituierte 2,6-Dimethyl-l,4dihydropyridine
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3714438A1 (de) * 1987-04-30 1988-11-10 Bayer Ag Optisch aktive dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
FI893066A0 (fi) 1989-06-22
FI893066A7 (fi) 1989-12-25
GR3022713T3 (en) 1997-06-30
JPH1067743A (ja) 1998-03-10
ES2098084T3 (es) 1997-04-16
EP0628538A1 (de) 1994-12-14
PT90943B (pt) 1994-11-30
JPH0253774A (ja) 1990-02-22
PT90943A (pt) 1989-12-29
DE3821334A1 (de) 1989-12-28
AU3644289A (en) 1997-01-23
KR910000643A (ko) 1991-01-29
US5138091A (en) 1992-08-11
US5017590A (en) 1991-05-21
ZA894778B (en) 1990-03-28
ATE148095T1 (de) 1997-02-15
DD284001A5 (de) 1990-10-31
ATE149154T1 (de) 1997-03-15
EP0628538B1 (de) 1997-01-22
EP0347678A2 (de) 1989-12-27
CN1039583A (zh) 1990-02-14
HUT50772A (en) 1990-03-28
DE58909778D1 (de) 1997-04-03
IL90696A0 (en) 1990-01-18
DK312989D0 (da) 1989-06-23
EP0347678A3 (de) 1990-12-05
DE58909770D1 (de) 1997-03-06
EP0347678B1 (de) 1997-02-26
CA1337074C (en) 1995-09-19

Similar Documents

Publication Publication Date Title
ES2062009T4 (es) Agentes antifungicos derivados de triazol
DE59105815D1 (de) 1,4,7,10-Tetraazacyclododecan-butyltriole, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel.
DK0509398T3 (da) Quinoxaliner, fremgangsmåder til deres fremstilling samt deres anvendelse
DK0513543T3 (da) Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og antikoagulationsmidler med indehold deraf
DK0571420T4 (da) Mycobakteriepolypeptider og for disse kodende nucleinsyrer til diagnose og behandling af tuberkulose
DK0580502T3 (da) 3-(hydroxybenzylidenyl)-indolin-2-oner og farmaceutiske sammensætninger indeholdende disse
FR2619111B1 (fr) Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
KR900700463A (ko) 6-치환 비환식 피리미딘 뉴클레오시드 유도체 및 그 유도체를 유효성분으로 하는 항 비루스재
ES2097490T3 (es) Composiciones farmaceuticas a base de ebastina o de sus analogos.
DK216388D0 (da) 1,2,5,6-tetrahydropyridinderivater, deres fremstilling og laegemidler med indhold deraf
NO940831D0 (no) Diiodforbindelser for anvendelse ved fremstilling av morfolinylderivater av doxorubicin, og deres fremstilling
DK0450420T3 (da) Heterocyclisk substituerede dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
NO881308D0 (no) Dihydropyridinamider, fremgangsmaate til deres fremstilling og deres anvendelse i legemidler.
DK0646578T3 (da) Phenylcarboxamidisoxazoler og deres salte, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmace
DK312989D0 (da) 1,4-dihydropyridin-threonin-derivater og fysiologisk uskadelige salte deraf, deres fremstilling og anvendelse samt mellemprodukter til fremstillingen
DK0564358T3 (da) 3-aminochroman-spiro-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne
DK0411408T3 (da) Monoklint metazachlor og fremgangsmåde til fremstilling heraf
DK282285A (da) Hidtil ukendte 8-alkylthio-2-piperazino-pyrimido(5,4-d)pyrimidiner,deres fremstilling og laegemidler indeholdende disse forbindelser
DK0658557T3 (da) Eburnan-derivater, fremgangsmåde til fremstilling af sådanne derivater og farmaceutiske sammensætninger indeholdende disse
FI870176A0 (fi) Nya foereningar och deras framstaellningsfoerfaranden.
DK284588D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
NO932418D0 (no) Pyrimidinderivater, fremgangsmaate for deres fremstilling og terapeutiske anvendelse derav
ATE100996T1 (de) Blattglanzmittel.
DK0432898T3 (da) Glutarsyrederivater og fremstillingen deraf
DE68922596D1 (de) 3-(3-Ethyl-1,2,4-oxadiazol-5-yl)-1-azabicycloheptan, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen.

Legal Events

Date Code Title Description
ATS Application withdrawn